Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes.
about
Liraglutide reduces body weight by upregulation of adenylate cyclase 3.Incretin-based therapies in prediabetes: Current evidence and future perspectivesWeight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study.Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.Pharmacotherapy for obesity: novel agents and paradigms.GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents.Liraglutide: an injectable option for the management of obesity.Cardiometabolic Effects of Glucagon-Like Peptide-1 Agonists.Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice.Dissecting the relationship between obesity and hyperinsulinemia: Role of insulin secretion and insulin clearance.Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.European Guidelines for Obesity Management in Adults.Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.Effects of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose: A Pilot Study.Effect of liraglutide on physical performance in type 2 diabetes (LIPER2): A randomised, double-blind, controlled trial.Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol.
P2860
Q33920059-157EB17D-30BF-4A01-AF1A-C8F3A0786782Q34699191-5F16C4B4-C10A-4994-9635-DCC9BEE73829Q35209811-A04A0F10-C349-4A10-ACB3-5A8DCA7A6CF8Q37353814-51D2B0A2-6FE3-45C9-85C1-A6C437FFB0E5Q37470522-E776C690-5F58-4260-BA67-EDFC8E9472FBQ37712227-C7D6585F-B345-4CF8-89EB-721F9B86FDA3Q38266329-2898C568-50FF-47FF-B305-3AFD6EB932CBQ38488897-60FE414E-A967-4579-925D-8ECE398D0895Q38702260-233D5794-83A2-4E1F-BF29-2A277CA69C3EQ38794395-378CBB90-85D0-433A-AF76-112731E772C9Q39489506-34122BD7-4718-4C8A-854C-E61D9A49E9E1Q42060078-6E3130C1-BE94-4836-BD08-497D00A2DD01Q46325597-E820F064-3210-499A-BEC7-0FA69F55109FQ47094048-A8D98589-AB87-419E-8FC8-06E136C76E8EQ48935307-9A610190-BA89-4684-BA19-7DD96D543658Q51269837-8F9B2995-55B3-4082-BB49-DCF4A8A6D43AQ55137041-62994D87-E53A-46D2-8160-FFF06F7C3DB2Q55215230-5931BD14-B0F3-4D54-ACC3-461F999E4240
P2860
Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Benefits of liraglutide treatm ...... individuals with prediabetes.
@en
Benefits of liraglutide treatm ...... individuals with prediabetes.
@nl
type
label
Benefits of liraglutide treatm ...... individuals with prediabetes.
@en
Benefits of liraglutide treatm ...... individuals with prediabetes.
@nl
prefLabel
Benefits of liraglutide treatm ...... individuals with prediabetes.
@en
Benefits of liraglutide treatm ...... individuals with prediabetes.
@nl
P2093
P2860
P356
P1433
P1476
Benefits of liraglutide treatm ...... individuals with prediabetes.
@en
P2093
Danit Ariel
Fahim Abbasi
Hector Ochoa
Kaylene Grove
Patricia Schaaf
Vanessa Tomasso
Yeheng V Liu
Yii-Der Ida Chen
P2860
P304
P356
10.2337/DC13-0354
P407
P577
2013-07-08T00:00:00Z